New Topics in Vasopressin Receptors and Approach to Novel Drugs: Role of the Vasopressin Receptor in Psychological and Cognitive Functions
Arginine vasopressin (AVP) is a neurohypophyseal peptide best known as an antidiuretic hormone. AVP receptors have been classified into three subtypes: V1a, V1b, and V2 receptors. V1a receptor (V1aR) and V1b receptor (V1bR) are widely distributed in the central nervous system, including the septum,...
Main Authors: | Nobuaki Egashira, Kenichi Mishima, Katsunori Iwasaki, Ryozo Oishi, Michihiro Fujiwara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319312964 |
Similar Items
-
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Vasopressin and Pain Perception
by: Taka-aki Koshimizu, et al.
Published: (2009-01-01) -
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Effects of Vasopressin Receptor on Regulations of Hormone Secretion and Metabolisms of Glucose, Fat, and Protein
by: Akito Tanoue
Published: (2009-01-01) -
Involvement of GABAA Receptors in the Neuroprotective Effect of Theanine on Focal Cerebral Ischemia in Mice
by: Nobuaki Egashira, et al.
Published: (2007-01-01) -
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Involvement of Vasopressin V1a and V1b Receptors in Nociceptive Responses and Morphine-Induced Effects
by: Kenji Honda, et al.
Published: (2009-01-01) -
2,5-Dimethoxy-4-iodoamphetamine (DOI) Inhibits ∆9-Tetrahydrocannabinol-Induced Catalepsy-Like Immobilization in Mice
by: Nobuaki Egashira, et al.
Published: (2007-01-01)